Search Results - "Evenepoel, P"

Refine Results
  1. 1

    Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease by Meijers, B., Jouret, F., Evenepoel, P.

    Published in Pharmacological research (01-07-2018)
    “…[Display omitted] Bidirectional interactions exist between the kidneys and the gut. These interactions are commonly referred to as the gut-kidney axis. Chronic…”
    Get full text
    Journal Article Web Resource
  2. 2

    Vitamin K in CKD Bone Disorders by Fusaro, M., Cianciolo, G., Evenepoel, P., Schurgers, L., Plebani, M.

    Published in Calcified tissue international (01-04-2021)
    “…Vitamin K is principally known because it is involved in blood coagulation. Furthermore, epidemiological studies showed that its deficit was associated with…”
    Get full text
    Journal Article
  3. 3

    Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients by Bammens, B., Evenepoel, P., Keuleers, H., Verbeke, K., Vanrenterghem, Y.

    Published in Kidney international (01-03-2006)
    “…Based on in vitro data, protein-bound uremic retention solutes have increasingly been recognized to play a pathophysiological role in the uremic syndrome…”
    Get full text
    Journal Article
  4. 4

    Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism by Evenepoel, P., Cunningham, J., Ferrari, S., Haarhaus, M., Javaid, M.K., Lafage-Proust, M.-H., Prieto-Alhambra, D., Torres, P.U., Cannata-Andia, J.

    Published in Osteoporosis international (01-12-2021)
    “…The European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) CKD-MBD working group, in collaboration with the Committee of Scientific…”
    Get full text
    Journal Article
  5. 5

    Therapy-Resistant Hypercalcemia in a Patient with Inactivating CYP24A1 Mutation and Recurrent Nephrolithiasis: Beware of Concomitant Hyperparathyroidism by David, K., Khalil, R., Hannon, H., Evenepoel, P., Decallonne, B.

    Published in Calcified tissue international (01-11-2020)
    “…We describe a case harboring a homozygous CYP24A1 mutation with mild loss of function, first presenting with recurrent nephrolithiasis from the age of 22…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Sclerostin Serum Levels and Vascular Calcification Progression in Prevalent Renal Transplant Recipients by Evenepoel, P, Goffin, E, Meijers, B, Kanaan, N, Bammens, B, Coche, E, Claes, K, Jadoul, M

    “…Context: Vascular calcification (VC) is prevalent and progressive in renal transplant recipients (RTRs). Recent cross-sectional data suggest that activated Wnt…”
    Get full text
    Journal Article
  8. 8

    Free p-cresol is associated with cardiovascular disease in hemodialysis patients by Meijers, B.K.I., Bammens, B., De Moor, B., Verbeke, K., Vanrenterghem, Y., Evenepoel, P.

    Published in Kidney international (01-05-2008)
    “…Cardiovascular disease (CVD) is highly prevalent in chronic kidney disease, suggesting that molecules retained in uremia might contribute to this increased…”
    Get full text
    Journal Article
  9. 9

    Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: a Belgium and the Netherlands survey by Hamdy, N. A. T., Decallonne, B., Evenepoel, P., Gruson, D., van Vlokhoven-Verhaegh, L.

    Published in Journal of endocrinological investigation (01-07-2021)
    “…Purpose To determine the burden of illness in patients with not adequately controlled chronic hypoparathyroidism receiving conventional therapy in Belgium and…”
    Get full text
    Journal Article
  10. 10

    Tertiary ‘Hyperphosphatoninism’ Accentuates Hypophosphatemia and Suppresses Calcitriol Levels in Renal Transplant Recipients by Evenepoel, P., Naesens, M., Claes, K., Kuypers, D., Vanrenterghem, Y.

    Published in American journal of transplantation (01-05-2007)
    “…Hypophosphatemia and inappropriately low calcitriol levels are frequently observed following successful renal transplantation. Fibroblast growth factor‐23…”
    Get full text
    Journal Article
  11. 11

    A Randomized Study Evaluating Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients With Persistent Hyperparathyroidism by Evenepoel, P., Cooper, K., Holdaas, H., Messa, P., Mourad, G., Olgaard, K., Rutkowski, B., Schaefer, H., Deng, H., Torregrosa, J. V., Wuthrich, R. P., Yue, S.

    Published in American journal of transplantation (01-11-2014)
    “…Persistent hyperparathyroidism (HPT) after kidney transplantation (KTx) is associated with hypercalcemia, hypophosphatemia and abnormally high levels of…”
    Get full text
    Journal Article
  12. 12

    Androgen therapy does not prevent bone loss and arterial calcifications in male rats with chronic kidney disease by David, K, Dubois, V, Verhulst, A, Sommers, V, Schollaert, D, Deboel, L, Moermans, K, Carmeliet, G, D'Haese, P, Vanderschueren, D, Claessens, F, Evenepoel, P, Decallonne, B

    Published in Journal of endocrinology (01-06-2023)
    “…Patients suffering from chronic kidney disease (CKD) often experience bone loss and arterial calcifications. It is unclear if hypogonadism contributes to the…”
    Get full text
    Journal Article
  13. 13

    Inflammation and the bone-vascular axis in end-stage renal disease by Viaene, L., Behets, G. J., Heye, S., Claes, K., Monbaliu, D., Pirenne, J., D’Haese, P. C., Evenepoel, P.

    Published in Osteoporosis international (01-02-2016)
    “…Summary Bone loss and vascular calcification coincide in patients with end-stage renal disease, similar as to what is observed in the general population. In…”
    Get full text
    Journal Article
  14. 14

    Chronic Histological Damage in Early Indication Biopsies Is an Independent Risk Factor for Late Renal Allograft Failure by Naesens, M., Kuypers, D. R. J., De Vusser, K., Vanrenterghem, Y., Evenepoel, P., Claes, K., Bammens, B., Meijers, B., Lerut, E.

    Published in American journal of transplantation (01-01-2013)
    “…The impact of early histological lesions of renal allografts on long‐term graft survival remains unclear. We included all renal allograft recipients…”
    Get full text
    Journal Article
  15. 15

    Update on the role of bone biopsy in the management of patients with CKD–MBD by Evenepoel, P., Behets, G. J. S., Laurent, M. R., D’Haese, P. C.

    Published in Journal of nephrology (01-10-2017)
    “…Patients with chronic kidney disease (CKD) are at increased risk of fractures. The fracture risk steadily increases along with the progression of renal disease…”
    Get full text
    Journal Article
  16. 16

    The Effect of Anastomosis Time on Outcome in Recipients of Kidneys Donated After Brain Death: A Cohort Study by Heylen, L., Naesens, M., Jochmans, I., Monbaliu, D., Lerut, E., Claes, K., Heye, S., Verhamme, P., Coosemans, W., Bammens, B., Evenepoel, P., Meijers, B., Kuypers, D., Sprangers, B., Pirenne, J.

    Published in American journal of transplantation (01-11-2015)
    “…Whether warm ischemia during the time to complete the vascular anastomoses determines renal allograft function has not been investigated systematically. We…”
    Get full text
    Journal Article
  17. 17

    Superior dialytic clearance of β2-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis by Evenepoel, P., Bammens, B., Verbeke, K., Vanrenterghem, Y.

    Published in Kidney international (28-08-2006)
    “…Both residual renal and dialytic clearance confer to the total solute clearance in dialysis patients. Dialytic clearances of the middle molecule…”
    Get full text
    Journal Article
  18. 18

    Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis by Evenepoel, P, Bammens, B, Verbeke, K, Vanrenterghem, Y

    Published in Kidney international (01-08-2006)
    “…Both residual renal and dialytic clearance confer to the total solute clearance in dialysis patients. Dialytic clearances of the middle molecule…”
    Get full text
    Journal Article
  19. 19

    Pro: cardiovascular calcifications are clinically relevant by Bover, Jordi, Evenepoel, Pieter, Ureña-Torres, Pablo, Vervloet, Marc G, Brandenburg, Vincent, Mazzaferro, Sandro, Covic, Adrian, Goldsmith, David, Massy, Ziad A, Cozzolino, Mario

    Published in Nephrology, dialysis, transplantation (01-03-2015)
    “…It is increasingly acknowledged that mineral and bone disorders (MBDs) contribute to the excessively high cardiovascular (CV) disease morbidity and mortality…”
    Get full text
    Journal Article
  20. 20